×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
The Globalization of Risk Management
Session Chair(s)
Jamie Wilkins, PharmD
Head, Risk Management Center of Excellence
Pfizer Inc, United States
This session will review the key REMS and EU Risk Management guidances issued during 2024. It will review the major strategic and operational impacts of the new guidances and describe practical applications of the new approaches they describe.
Learning Objective : Review the overview and intent of key risk management guidances issued by the FDA and EMA; Compare the key differences and similarities in the approaches outlined in the guidelines; Identify key areas of activity for organizations to align with the intent of these guidances; Evaluate the key strategic and operational impacts of the guidances on participants' organizations.
Have an account?